Flexion Therapeutics, Inc. (FLXN) Trades at $28.49 After Triangle; Firefly Value Partners LP Has Increased Its Wells Fargo & Co (WFC) Holding

Wells Fargo & Company (NYSE:WFC) Logo

Flexion Therapeutics, Inc. (FLXN) formed triangle with $27.63 target or 3.00% below today’s $28.49 share price. Flexion Therapeutics, Inc. (FLXN) has $1.07 billion valuation. The stock increased 3.92% or $1.075 during the last trading session, reaching $28.485. About 161,749 shares traded. Flexion Therapeutics, Inc. (NASDAQ:FLXN) has risen 39.11% since June 20, 2017 and is uptrending. It has outperformed by 26.54% the S&P500. Some Historical FLXN News: ; 06/03/2018 Flexion Therapeutics Presents Clinical Data at AAOS 2018 Annual Meeting and the American Pain Society Annual Scientific Meeting; 04/05/2018 – FLEXION: CMS INCLUDED ZILRETTA FOR HCPCS J CODE; 08/05/2018 – Flexion Therapeutics 1Q Loss $41.6M; 26/04/2018 – Flexion Therapeutics: Average Time to Second ZILRETTA Admin Was More Than 16 Weeks; 04/05/2018 – Flexion Therapeutics Announces ZILRETTA(R) (triamcinolone Acetonide Extended-Release Injectable Suspension) Recommended for Unique J Code by CMS; 06/03/2018 – FLEXION: ZILRETTA DATA SHOWS POTENTIAL TO PROVIDE PAIN RELIEF; 04/05/2018 – FLEXION THERAPEUTICS ZILRETTA RECOMMENDED BY CMS; 26/03/2018 – Flexion Therapeutics Presenting at Conference Tomorrow; 08/05/2018 – FLEXION THERAPEUTICS INC QTRLY SHR LOSS $1.10; 06/04/2018 – Flexion Therapeutics Reports Inducement Grants Under NASDAQ Listing Rule 5635(c)(4)

Firefly Value Partners Lp increased Wells Fargo & Co (WFC) stake by 1.27% reported in 2018Q1 SEC filing. Firefly Value Partners Lp acquired 13,869 shares as Wells Fargo & Co (WFC)’s stock declined 8.45%. The Firefly Value Partners Lp holds 1.11 million shares with $57.99M value, up from 1.09M last quarter. Wells Fargo & Co now has $269.88 billion valuation. The stock increased 0.55% or $0.305 during the last trading session, reaching $55.385. About 844,424 shares traded. Wells Fargo & Company (NYSE:WFC) has risen 4.02% since June 20, 2017 and is uptrending. It has underperformed by 8.55% the S&P500. Some Historical WFC News: ; 11/04/2018 – DEADLINE ALERT: Bronstein, Gewirtz & Grossman, LLC Reminds Investors of Class Action Against Wells Fargo & Company (WFC) and Lead Plaintiff Deadline: April 16, 2018; 24/04/2018 – LyondellBasell to Address Wells Fargo Industrials Conference; 26/04/2018 – Textainer Group at Wells Fargo Industrials Conference May 9; 15/05/2018 – OMEGA ADVISORS DISSOLVES SHARE STAKE IN ZYNGA; 20/04/2018 – Wells Fargo to Pay $1 Billion to Settle CFPB, OCC Probes (Video); 17/05/2018 – Ed Blakey to Retire After 34 Years with Wells Fargo; 08/05/2018 – Aptiv Presenting at Wells Fargo Industrials Conference Tomorrow; 10/05/2018 – WELLS FARGO `THROUGH MOST’ OF HISTORICAL BUSINESS REVIEW: SLOAN; 07/05/2018 – Wells Fargo Launches ‘Re-Established,’ a New Brand Campaign; 04/05/2018 – WELLS FARGO: CO. WILL PAY $480M

More notable recent Wells Fargo & Company (NYSE:WFC) news were published by: Bizjournals.com which released: “Wells Fargo sheds almost 100 jobs in pricey San Francisco” on June 19, 2018, also Seekingalpha.com with their article: “WSJ: Wells Fargo planning to restructure wealth management business” published on June 18, 2018, Fool.com published: “Is Wells Fargo & Company a Buy?” on June 15, 2018. More interesting news about Wells Fargo & Company (NYSE:WFC) were released by: Fool.com and their article: “How Wells Fargo Is Following in Bank of America’s Footsteps” published on June 11, 2018 as well as Seekingalpha.com‘s news article titled: “Wells Fargo: Only Buy On Weakness” with publication date: May 26, 2018.

Investors sentiment decreased to 0.59 in Q1 2018. Its down 0.16, from 0.75 in 2017Q4. It worsened, as 108 investors sold WFC shares while 790 reduced holdings. 122 funds opened positions while 412 raised stakes. 3.62 billion shares or 0.62% less from 3.64 billion shares in 2017Q4 were reported. First Western Cap owns 2.43% invested in Wells Fargo & Company (NYSE:WFC) for 9,754 shares. 100,501 were accumulated by Kentucky Retirement Insurance Tru Fund. Grisanti Mngmt Ltd reported 7.12% in Wells Fargo & Company (NYSE:WFC). Sterneck Capital Management Lc stated it has 47,248 shares. Addenda Inc invested in 148,212 shares. Texas Permanent School Fund has 0.79% invested in Wells Fargo & Company (NYSE:WFC) for 1.13M shares. Compass Capital Mgmt accumulated 7,163 shares. Ohio-based Pub Employees Retirement System Of Ohio has invested 0.85% in Wells Fargo & Company (NYSE:WFC). North Star Asset Mgmt has invested 0.15% in Wells Fargo & Company (NYSE:WFC). Ny State Common Retirement Fund has 13.78M shares for 0.9% of their portfolio. Legacy Private Trust reported 11,005 shares. Bb&T Securities Lc holds 0.63% or 1.06 million shares in its portfolio. Rothschild Asset Management Inc holds 0.34% of its portfolio in Wells Fargo & Company (NYSE:WFC) for 584,301 shares. Meristem Llp stated it has 51,293 shares or 0.96% of all its holdings. Whitnell And invested in 3,052 shares.

Among 39 analysts covering Wells Fargo & Company (NYSE:WFC), 17 have Buy rating, 8 Sell and 14 Hold. Therefore 44% are positive. Wells Fargo & Company had 149 analyst reports since July 29, 2015 according to SRatingsIntel. The stock of Wells Fargo & Company (NYSE:WFC) has “Neutral” rating given on Wednesday, January 11 by UBS. The rating was maintained by S&P Research on Thursday, August 13 with “Buy”. Piper Jaffray maintained the stock with “Hold” rating in Friday, October 13 report. On Thursday, September 28 the stock rating was maintained by Nomura with “Buy”. As per Tuesday, September 5, the company rating was maintained by Robert W. Baird. Guggenheim downgraded the shares of WFC in report on Wednesday, April 6 to “Neutral” rating. Sandler O’Neill maintained the shares of WFC in report on Thursday, March 29 with “Buy” rating. The rating was maintained by UBS with “Sell” on Thursday, September 15. As per Monday, October 10, the company rating was upgraded by UBS. The firm has “Buy” rating by RBC Capital Markets given on Thursday, July 27.

Since May 24, 2018, it had 0 insider purchases, and 1 insider sale for $1.40 million activity. 25,567 shares valued at $1.40 million were sold by Pelos Petros G on Thursday, May 24.

Analysts await Flexion Therapeutics, Inc. (NASDAQ:FLXN) to report earnings on August, 14. They expect $-1.22 earnings per share, down 34.07% or $0.31 from last year’s $-0.91 per share. After $-1.10 actual earnings per share reported by Flexion Therapeutics, Inc. for the previous quarter, Wall Street now forecasts 10.91% negative EPS growth.

Among 10 analysts covering Flexion Therapeutics (NASDAQ:FLXN), 10 have Buy rating, 0 Sell and 0 Hold. Therefore 100% are positive. Flexion Therapeutics had 24 analyst reports since July 31, 2015 according to SRatingsIntel. As per Tuesday, May 3, the company rating was reinitiated by Wells Fargo. Needham maintained Flexion Therapeutics, Inc. (NASDAQ:FLXN) on Wednesday, September 9 with “Buy” rating. The firm has “Buy” rating given on Monday, September 11 by RBC Capital Markets. The company was maintained on Monday, June 26 by BMO Capital Markets. As per Monday, October 9, the company rating was maintained by BMO Capital Markets. The stock has “Outperform” rating by BMO Capital Markets on Wednesday, June 29. The firm has “Buy” rating by Cantor Fitzgerald given on Wednesday, November 4. The rating was maintained by Northland Capital on Wednesday, October 4 with “Buy”. BMO Capital Markets maintained Flexion Therapeutics, Inc. (NASDAQ:FLXN) rating on Friday, March 9. BMO Capital Markets has “Outperform” rating and $36 target. The rating was initiated by Lake Street on Thursday, July 21 with “Buy”.

Wells Fargo & Company (NYSE:WFC) Institutional Positions Chart